Cargando…
The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
Influenza vaccines are a fundamental tool for preventing the disease and reducing its consequences, particularly in specific high-risk groups. In order to be licensed, influenza vaccines have to meet strict criteria established by European Medicines Agency. Although the licensure of influenza vaccin...
Autores principales: | Gianchecchi, E, Torelli, A, Montomoli, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605831/ https://www.ncbi.nlm.nih.gov/pubmed/30614754 http://dx.doi.org/10.1080/21645515.2019.1565269 |
Ejemplares similares
-
Influenza vaccines: Evaluation of the safety profile
por: Trombetta, Claudia Maria, et al.
Publicado: (2018) -
Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
por: Montomoli, Emanuele, et al.
Publicado: (2018) -
Sea buckthorn bud extract displays activity
against cell-cultured Influenza virus
por: TORELLI, A., et al.
Publicado: (2015) -
Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
por: Gianchecchi, Elena, et al.
Publicado: (2023) -
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
por: Gianchecchi, Elena, et al.
Publicado: (2022)